MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.

Fluent BioSciences Inc
Fluent BioSciences Inc

The emergence of single-cell genomics has enabled unprecedented access to cellular and subcellular variation in genotype and phenotype powering a revolution in precision medicine. Current commercial solutions for processing single cell (>$250M emerging market) and cancer monitoring (>$500M established market) samples are expensive, time-consuming, and challenged by limited sample input. Fluent’s radical, proprietary, reagent-only platform is poised to disrupt the $40B/yr drug discovery market.
Our high sensitivity reagent tools revolutionize the way pharma companies conduct early drug screening at the single cell and molecule level

Connect with Fluent BioSciences Inc


2019 Finalist Boston

Sub industry


Additional Industries
Therapeutics (Pharma / Biotech)


MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.